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Background/Introduction
The St. Jude Medical Trifecta aortic supra-annular bio-
prosthesis is regarded as the next generation in pericardial
stented tissue valves. The unique design of tissue leaflets
attached to the exterior of the valve stent provides unri-
valled in-vivo mean gradients and haemodynamics.
Aims/Objectives
The aim of this prospective study was to evaluate midterm
haemodynamic performance of valve implanted into
patients under 65.
Method
Thirty consecutive patients undergoing aortic valve repla-
cement using the St. Jude Medical Trifecta valve at a single
UK centre over a 48-month period were included in this
study. Patients undergoing concomitant cardiac proce-
dures were included. All implanted valves were 21, 23, 25
and 27 mm in size. Assessment of haemodynamic function
was carried out using transthoracic echocardiography pre-
operatively and at follow-up, as well as transoesophageal
echocardiography intra-operatively.
Results
The study population consisted of 30 patients (22 male,
8 female). Mean age was 52.63 ± 11.8 years. Implanted
valve sizes were 21 mm (n = 9), 23 mm (n = 11), 25 mm
(n = 7) and 27 mm (n = 3). Overall mean post-operative
pressure gradients were 11.3 ± 5.8 mmHg (mean) and
19.54 ± 9.5 mmHg (peak). Subgroup mean post-operative
pressure gradients were 18.37 ± 4.6 mmHg, 9.8 ± 2.2
mmHg, 9.46 ± 2.54 mmHg, 7.78 ± 2.3 mmHg for the 21,
23, 25 and 27 mm cohort respectively. Overall mean
post-operative left ventricular ejection fraction was
54.9 ± 3.3%. Overall mean effective orifice area was
1.95 ± 0.7 cm2.
Discussion/Conclusion
These results of our experience demonstrate excellent
haemodynamic performance of the Trifecta bioprosthetic
valve in young patients under 65.
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